SCHEMBL4094737

SCHEMBL4094737

CNC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2c1CCCC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.55
MAPT P10636 7/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 4/20 0.53
HSD17B10 Q99714 2/20 0.53
HPGD P15428 2/20 0.53
CASP1 P29466 2/20 0.53
CASP7 P55210 2/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
RAB9A P51151 3/20 0.53
POLB P06746 3/20 0.53
CNR2 P34972 3/20 0.53
FLT3 P36888 2/20 0.52
NPC1 O15118 2/20 0.52
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 1/20 0.51
LMNA P02545 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4093212 0.87 KDM4E (0.54) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4086799 0.86 PTPN1 (0.63) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4085782 0.86 CYP1A2 (0.71) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4090439 0.86 CNR2 (0.50) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL5453482 0.85 MAPT (0.72) ATMMAPTMEN1KMT2AALDH1A1
SCHEMBL4090029 0.84 CNR2 (0.48) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4084167 0.84 CNR2 (0.74) ATMMEN1KMT2AALDH1A1CNR2
SCHEMBL4090251 0.84 CNR2 (0.62) ATMMAPTMEN1KMT2AALDH1A1
SCHEMBL4091622 0.84 PTPN1 (0.63) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4091289 0.83 CNR2 (0.55) ATMMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338623-B2 N-{3-[(2,5-dimethylmorpholin-4-yl)carbonyl]-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl}hexahydro-2,5-methanopentalene-3a(1H)-carboxamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants ABBVIE INC. (US) 2012-12-25 US disclosed
US-20090018114-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018114-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, GPR18 ATM 3672/4885MAPT 2527/4885MEN1 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.